Trial Outcomes & Findings for Microalbuminuria in Children With and Without Diabetes (NCT NCT00320086)
NCT ID: NCT00320086
Last Updated: 2024-01-31
Results Overview
Recruitment status
COMPLETED
Target enrollment
203 participants
Primary outcome timeframe
during hospitalization
Results posted on
2024-01-31
Participant Flow
Patients were recruited from the University of New Mexico and via advertising and referral by other physicians.
Participant milestones
| Measure |
Arm 1
Control Arm: Evaluate Normal Urinary Protein Excretion in Healthy and Diabetic Children
|
Arm 2
Diabetes Arm: Children 6 to 18 years old with Type I or Type II Diabetes
|
|---|---|---|
|
Overall Study
STARTED
|
91
|
112
|
|
Overall Study
COMPLETED
|
91
|
112
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Microalbuminuria in Children With and Without Diabetes
Baseline characteristics by cohort
| Measure |
Arm 1
n=91 Participants
Control Arm: children 6 to 18 years old without:
* kidney disease
* abnormal body temperature
* history of documented urinary tract infection
* metabolic disease
* circulatory disease
* liver disease
* strenuous exercise in prior 24 hours
* nocturnal enuresis
|
Arm 2
n=112 Participants
Diabetes Arm: children 6 to 18 years old with Type I or Type II Diabetes without:
* kidney disease
* abnormal body temperature
* history of documented urinary tract infection
* metabolic disease other than diabetes mellitus
* circulatory disease
* liver disease
* strenuous exercise in prior 24 hours
* nocturnal enuresis
|
Total
n=203 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
91 Participants
n=5 Participants
|
112 Participants
n=7 Participants
|
203 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
45 Participants
n=5 Participants
|
57 Participants
n=7 Participants
|
102 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
46 Participants
n=5 Participants
|
55 Participants
n=7 Participants
|
101 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: during hospitalizationOutcome measures
| Measure |
Arm 1
n=91 Participants
Control Arm
|
Arm 2
n=112 Participants
Diabetes Arm
|
|---|---|---|
|
Number of Subjects With Normal Urinary Protein Excretion in Healthy and Diabetic Children, Assessed Over 1 Day.
|
91 participants
|
112 participants
|
Adverse Events
Group 1
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place